2[2]Bartlett JG. Management of Clostridium difficile infection and other antibiotic - associated diarrhoeas[J]. Eur J Gastroenterol Hepatol, 1996,8:1 054.
3[3]McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention ofβ- lactam- associated diarrhea [J]. Gastroenterology, 1995,90:438.
4[4]Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of saccharomyces boulardii in the prevention of antibioticrelated diarrhoea in elderly patients [J] . J Infect, 1998,36:171.
5[5]Thamlikitkul V, Danpakdi K, Chokloikew S. Incidence of diarrhea and clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, β - lactams, or nonantibiotic medications [J] . J Clin Gastroenterol , 1996,22:161.
6[6]Wistr ma J, Norrby SR. Frequency of antibiotic-associated diarrhoea in 2 462 antibiotic - treated hospitalized patients: a prospective study [J]. J Anticicrob Chemother , 2001,47:43.
7[7]Alfa MJ, Du T, Beda G. Survey of incidence of clostridium difficile infection in canadian hospitals and diagnostic approaches[J]. J Clin Microbiol, 1998,36(7) :2 076.
8[8]Wilkins TD, Lyerly DM. Clostridium difficile testing: after 20years, still challenging [J]. Journal of Clinical Microbiology,2003,41 (2) :531.
9[9]Gorbach SL. Antibiotic and clostridium difficile[J]. N Engl J Med, 1999,341 (22): 1 689.
8McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of clostridium difficile disease [ J ]. Am J Gastroenterol, 2006,101 (4) :812-822.
9Turck D, Bernet JP, MarxIncidence J, et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population [ J ]. J Pediatr Gastroenterol Nutr, 2003, 37(1) :22-26.
10Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to clostridium difficile, clostridium perfringens, and staphylococcus aureus [ J ]. J Clin Microbiol, 2006, 44(8) :. 2785-2791.
